Walvax Biotechnology Co. Ltd.

Walvax Biotechnology, founded 2001, is a key Chinese vaccine manufacturer offering HPV, 13‑ and 23‑valent pneumococcal, meningococcal ACYW135, HiB conjugates, and DTaP. Its robust R&D‑to‑market pipeline positions it to capture expanding immunisation demand.

Headquarters: China (CHN)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

HQ: Kunming

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
300142	Walvax Biotechnology Co. Ltd. Cap: 20.8B \| P/E: 433.0	EQUITY	SHZ	CNY	CNE100000WN2	Active	📈